Amgen Cash on Hand 2010-2024 | AMGN

Amgen cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Amgen cash on hand for the quarter ending March 31, 2024 was $9.708B, a 69.24% decline year-over-year.
  • Amgen cash on hand for 2023 was $10.944B, a 17.61% increase from 2022.
  • Amgen cash on hand for 2022 was $9.305B, a 15.78% increase from 2021.
  • Amgen cash on hand for 2021 was $8.037B, a 24.51% decline from 2020.
Amgen Annual Cash on Hand
(Millions of US $)
2023 $10,944
2022 $9,305
2021 $8,037
2020 $10,647
2019 $8,911
2018 $29,304
2017 $41,678
2016 $38,085
2015 $31,382
2014 $27,026
2013 $19,401
2012 $24,061
2011 $20,641
2010 $17,422
2009 $13,442
Amgen Quarterly Cash on Hand
(Millions of US $)
2024-03-31 $9,708
2023-12-31 $10,944
2023-09-30 $34,741
2023-06-30 $34,248
2023-03-31 $31,561
2022-12-31 $9,305
2022-09-30 $11,478
2022-06-30 $7,183
2022-03-31 $6,544
2021-12-31 $8,037
2021-09-30 $12,921
2021-06-30 $8,082
2021-03-31 $10,566
2020-12-31 $10,647
2020-09-30 $12,360
2020-06-30 $11,421
2020-03-31 $8,012
2019-12-31 $8,911
2019-09-30 $20,853
2019-06-30 $21,758
2019-03-31 $26,301
2018-12-31 $29,304
2018-09-30 $29,921
2018-06-30 $29,395
2018-03-31 $32,172
2017-12-31 $41,678
2017-09-30 $41,351
2017-06-30 $39,227
2017-03-31 $38,398
2016-12-31 $38,085
2016-09-30 $37,980
2016-06-30 $35,034
2016-03-31 $34,740
2015-12-31 $31,382
2015-09-30 $31,120
2015-06-30 $29,993
2015-03-31 $27,118
2014-12-31 $27,026
2014-09-30 $28,075
2014-06-30 $26,188
2014-03-31 $19,802
2013-12-31 $19,401
2013-09-30 $22,558
2013-06-30 $22,018
2013-03-31 $21,271
2012-12-31 $24,061
2012-09-30 $25,374
2012-06-30 $22,475
2012-03-31 $19,374
2011-12-31 $20,641
2011-09-30 $17,676
2011-06-30 $19,172
2011-03-31 $15,358
2010-12-31 $17,422
2010-09-30 $17,049
2010-06-30 $14,523
2010-03-31 $14,117
2009-12-31 $13,442
2009-09-30 $14,013
2009-06-30 $11,965
2009-03-31 $10,378
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $160.190B $28.190B
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
Stock Name Country Market Cap PE Ratio
Vertex Pharmaceuticals (VRTX) United States $124.054B 31.92
Regeneron Pharmaceuticals (REGN) United States $114.209B 27.93
CSL (CSLLY) Australia $92.040B 0.00
GSK (GSK) United Kingdom $84.245B 10.06
Bristol Myers Squibb (BMY) United States $83.517B 39.24
Gilead Sciences (GILD) United States $81.055B 16.14
Moderna (MRNA) United States $53.665B 0.00
Biogen (BIIB) United States $33.733B 15.45
Argenex SE (ARGX) Netherlands $23.000B 0.00
BioNTech SE (BNTX) Germany $21.890B 184.16
Alnylam Pharmaceuticals (ALNY) United States $20.288B 0.00
Genmab (GMAB) Denmark $17.319B 20.30
Illumina (ILMN) United States $17.310B 123.48
BioMarin Pharmaceutical (BMRN) United States $15.857B 61.86
BeiGene (BGNE) Cayman Islands $15.579B 0.00
Incyte (INCY) United States $13.946B 21.57
Bio-Techne Corp (TECH) United States $11.956B 45.16
Sarepta Therapeutics (SRPT) United States $11.611B 1023.67
QIAGEN (QGEN) Netherlands $9.662B 20.64
Insmed (INSM) United States $9.499B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.085B 26.44
Vaxcyte (PCVX) United States $7.936B 0.00
Roivant Sciences (ROIV) United Kingdom $7.897B 0.00
Legend Biotech (LEGN) United States $7.738B 0.00
Exact Sciences (EXAS) United States $7.728B 0.00
Ascendis Pharma (ASND) Denmark $7.433B 0.00
Intra-Cellular Therapies (ITCI) United States $7.155B 0.00
Repligen (RGEN) United States $7.019B 91.69
Blueprint Medicines (BPMC) United States $6.609B 0.00
Exelixis (EXEL) United States $6.592B 33.97
Halozyme Therapeutics (HALO) United States $6.300B 17.49
Viking Therapeutics (VKTX) United States $5.736B 0.00
Cytokinetics (CYTK) United States $5.655B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.397B 0.00
Apellis Pharmaceuticals (APLS) United States $5.097B 0.00
Krystal Biotech (KRYS) United States $5.077B 0.00
Nuvalent (NUVL) United States $5.021B 0.00
Zealand Pharma (ZLDPF) Denmark $4.763B 0.00
Alkermes (ALKS) Ireland $4.146B 16.23
ImmunityBio (IBRX) United States $4.122B 0.00
Immunovant (IMVT) United States $3.797B 0.00
Avidity Biosciences (RNA) United States $3.791B 0.00
Guardant Health (GH) United States $3.697B 0.00
Axsome Therapeutics (AXSM) United States $3.497B 0.00
Merus (MRUS) Netherlands $3.319B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.246B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.157B 0.00
Amicus Therapeutics (FOLD) United States $3.003B 0.00
Biohaven (BHVN) United States $2.987B 0.00
Denali Therapeutics (DNLI) United States $2.956B 0.00
Arcellx (ACLX) United States $2.911B 0.00
Twist Bioscience (TWST) United States $2.902B 0.00
Geron (GERN) United States $2.889B 0.00
IDEAYA Biosciences (IDYA) United States $2.884B 0.00
SpringWorks Therapeutics (SWTX) United States $2.856B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.811B 0.00
MorphoSys AG (MOR) Germany $2.732B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.646B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.608B 0.00
ADMA Biologics Inc (ADMA) United States $2.464B 96.64
ACADIA Pharmaceuticals (ACAD) United States $2.463B 0.00
Intellia Therapeutics (NTLA) United States $2.426B 0.00
Apogee Therapeutics (APGE) United States $2.405B 0.00
Certara (CERT) United States $2.395B 55.15
CG Oncology (CGON) United States $2.310B 0.00
Celldex Therapeutics (CLDX) United States $2.285B 0.00
Iovance Biotherapeutics (IOVA) United States $2.283B 0.00
Structure Therapeutics (GPCR) United States $2.246B 0.00
Janux Therapeutics (JANX) United States $2.178B 0.00
Fortrea Holdings (FTRE) United States $2.143B 26.34
Myriad Genetics (MYGN) United States $2.100B 0.00
Vericel (VCEL) United States $2.055B 0.00
Beam Therapeutics (BEAM) United States $2.047B 0.00
Kymera Therapeutics (KYMR) United States $2.043B 0.00
Novavax (NVAX) United States $2.022B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.985B 0.00
Vera Therapeutics (VERA) United States $1.970B 0.00
Protagonist Therapeutics (PTGX) United States $1.958B 13.68
Immunocore Holdings (IMCR) United Kingdom $1.923B 0.00
Zai Lab (ZLAB) China $1.854B 0.00
Bavarian Nordic (BVNRY) Denmark $1.804B 7.86
Keros Therapeutics (KROS) United States $1.781B 0.00
Arvinas (ARVN) United States $1.757B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.709B 0.00
NeoGenomics (NEO) United States $1.683B 0.00
Galapagos (GLPG) Belgium $1.676B 0.00
Akero Therapeutics (AKRO) United States $1.658B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.650B 12.58
Edgewise Therapeutics (EWTX) United States $1.635B 0.00
Kura Oncology (KURA) United States $1.586B 0.00
Neumora Therapeutics (NMRA) United States $1.560B 0.00
Arcus Biosciences (RCUS) United States $1.543B 0.00
Dynavax Technologies (DVAX) United States $1.512B 192.50
Belite Bio (BLTE) United States $1.489B 0.00
Ligand Pharmaceuticals (LGND) United States $1.441B 23.55
Sana Biotechnology (SANA) United States $1.347B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.332B 0.00
Vir Biotechnology (VIR) United States $1.327B 0.00
Morphic Holding (MORF) United States $1.325B 0.00
ANI Pharmaceuticals (ANIP) United States $1.313B 16.31
MannKind (MNKD) United States $1.307B 160.00
Spyre Therapeutics (SYRE) United States $1.269B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.224B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.222B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.197B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.170B 0.00
Disc Medicine (IRON) United States $1.144B 0.00
Immatics (IMTX) Germany $1.102B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.102B 0.00
Prothena (PRTA) Ireland $1.097B 0.00
Cullinan Therapeutics (CGEM) United States $1.088B 0.00
Tyra Biosciences (TYRA) United States $1.021B 0.00
MiMedx (MDXG) United States $1.008B 42.69
Arcutis Biotherapeutics (ARQT) United States $0.999B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.994B 0.00
Liquidia Technologies (LQDA) United States $0.988B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.988B 0.00
Tango Therapeutics (TNGX) United States $0.954B 0.00
AbCellera Biologics (ABCL) Canada $0.950B 0.00
Gyre Therapeutics (GYRE) United States $0.944B 0.00
Immunome (IMNM) United States $0.895B 0.00
89BIO (ETNB) United States $0.863B 0.00
Rapport Therapeutics (RAPP) $0.860B 0.00
Abivax SA (ABVX) France $0.855B 0.00
Prime Medicine (PRME) United States $0.853B 0.00
Stoke Therapeutics (STOK) United States $0.847B 0.00
Humacyte (HUMA) United States $0.840B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.835B 0.00
Mesoblast (MESO) Australia $0.831B 0.00
CureVac (CVAC) Germany $0.822B 0.00
PureTech Health (PRTC) United States $0.807B 0.00
Cogent Biosciences (COGT) United States $0.806B 0.00
Viridian Therapeutics (VRDN) United States $0.794B 0.00
Dianthus Therapeutics (DNTH) United States $0.763B 0.00
WAVE Life Sciences (WVE) Singapore $0.763B 0.00
Scholar Rock Holding (SRRK) United States $0.754B 0.00
HilleVax (HLVX) United States $0.750B 0.00
Nuvation Bio (NUVB) United States $0.746B 0.00
Nurix Therapeutics (NRIX) United States $0.746B 0.00
Cytek Biosciences (CTKB) United States $0.738B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.720B 0.00
Pliant Therapeutics (PLRX) United States $0.712B 0.00
Aerovate Therapeutics (AVTE) United States $0.710B 0.00
Olema Pharmaceuticals (OLMA) United States $0.691B 0.00
Praxis Precision Medicines (PRAX) United States $0.667B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.664B 0.00
CARGO Therapeutics (CRGX) United States $0.658B 0.00
AnaptysBio (ANAB) United States $0.649B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Zymeworks (ZYME) United States $0.639B 0.00
Castle Biosciences (CSTL) United States $0.633B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.628B 0.00
ArriVent BioPharma (AVBP) United States $0.626B 0.00
Mineralys Therapeutics (MLYS) United States $0.625B 0.00
GH Research (GHRS) Ireland $0.624B 0.00
REGENXBIO (RGNX) United States $0.611B 0.00
Pharming Group (PHGUF) Netherlands $0.606B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.596B 0.00
Arbutus Biopharma (ABUS) United States $0.593B 0.00
ITeos Therapeutics (ITOS) United States $0.586B 0.00
Pharming Group (PHAR) Netherlands $0.579B 0.00
Applied Therapeutics (APLT) United States $0.577B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.571B 0.00
PepGen (PEPG) United States $0.559B 0.00
Neurogene (NGNE) United States $0.553B 0.00
Third Harmonic Bio (THRD) United States $0.546B 0.00
Travere Therapeutics (TVTX) United States $0.546B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.544B 0.00
Entrada Therapeutics (TRDA) United States $0.533B 25.05
Terns Pharmaceuticals (TERN) United States $0.530B 0.00
Northwest Biotherapeutics (NWBO) United States $0.530B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.523B 0.00
Annexon (ANNX) United States $0.519B 0.00
Cabaletta Bio (CABA) United States $0.515B 0.00
Replimune (REPL) United States $0.514B 0.00
MaxCyte (MXCT) United States $0.512B 0.00
Oric Pharmaceuticals (ORIC) United States $0.505B 0.00
Astria Therapeutics (ATXS) United States $0.502B 0.00
Allogene Therapeutics (ALLO) United States $0.491B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.489B 0.00
Cartesian Therapeutics (RNAC) United States $0.486B 0.00
Oculis Holding AG (OCS) Switzerland $0.478B 0.00
Celcuity (CELC) United States $0.469B 0.00
Fulcrum Therapeutics (FULC) United States $0.463B 0.00
Voyager Therapeutics (VYGR) United States $0.463B 0.00
Adaptive Biotechnologies (ADPT) United States $0.461B 0.00
Alector (ALEC) United States $0.451B 0.00
Urogen Pharma (URGN) United States $0.450B 0.00
Absci (ABSI) United States $0.450B 0.00
Avid Bioservices (CDMO) United States $0.450B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.448B 0.00
TScan Therapeutics (TCRX) United States $0.444B 0.00
IGM Biosciences (IGMS) United States $0.430B 0.00
AC Immune (ACIU) Switzerland $0.421B 0.00
ALX Oncology Holdings (ALXO) United States $0.419B 0.00
Editas Medicine (EDIT) United States $0.416B 0.00
ACELYRIN, INC (SLRN) United States $0.414B 0.00
Contineum Therapeutics (CTNM) United States $0.412B 0.00
Precigen (PGEN) United States $0.411B 0.00
Fate Therapeutics (FATE) United States $0.411B 0.00
Kyverna Therapeutics (KYTX) United States $0.411B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.395B 0.00
EnGene Holdings (ENGN) United States $0.392B 0.00
Anika Therapeutics (ANIK) United States $0.383B 328.50
Jasper Therapeutics (JSPR) United States $0.377B 0.00
Erasca (ERAS) United States $0.376B 0.00
Ocugen (OCGN) United States $0.365B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.363B 0.00
Aura Biosciences (AURA) United States $0.363B 0.00
Agenus (AGEN) United States $0.325B 0.00
Alto Neuroscience (ANRO) United States $0.323B 0.00
Emergent Biosolutions (EBS) United States $0.323B 0.00
Nautilus Biotechnology (NAUT) United States $0.321B 0.00
Amarin (AMRN) Ireland $0.320B 0.00
Anavex Life Sciences (AVXL) United States $0.319B 0.00
Atea Pharmaceuticals (AVIR) United States $0.304B 0.00
Solid Biosciences (SLDB) United States $0.303B 0.00
C4 Therapeutics (CCCC) United States $0.301B 0.00
Nkarta (NKTX) United States $0.297B 0.00
Revance Therapeutics (RVNC) United States $0.295B 0.00
Shattuck Labs (STTK) United States $0.294B 0.00
XOMA (XOMA) United States $0.294B 0.00
Skye Bioscience (SKYE) United States $0.294B 0.00
Inozyme Pharma (INZY) United States $0.293B 0.00
Kamada (KMDA) Israel $0.293B 22.13
Scilex Holding (SCLX) United States $0.292B 0.00
MeiraGTx Holdings (MGTX) United States $0.289B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.285B 0.00
Sutro Biopharma (STRO) United States $0.283B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.273B 0.00
Poseida Therapeutics (PSTX) United States $0.268B 0.00
Tenaya Therapeutics (TNYA) United States $0.264B 0.00
CorMedix Inc (CRMD) United States $0.259B 0.00
Mersana Therapeutics (MRSN) United States $0.253B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.249B 0.00
Molecular Partners AG (MOLN) Switzerland $0.248B 0.00
Renovaro (RENB) United States $0.242B 0.00
Prima BioMed (IMMP) Australia $0.238B 0.00
UniQure (QURE) Netherlands $0.237B 0.00
Inovio Pharmaceuticals (INO) United States $0.236B 0.00
Ovid Therapeutics (OVID) United States $0.233B 0.00
FibroBiologics (FBLG) United States $0.233B 0.00
Inhibrx Biosciences (INBX) $0.227B 0.00
ChromaDex (CDXC) United States $0.225B 0.00
Q32 Bio (QTTB) United States $0.222B 0.00
Candel Therapeutics (CADL) United States $0.217B 0.00
Codexis (CDXS) United States $0.215B 0.00
Design Therapeutics (DSGN) United States $0.210B 0.00
GENFIT S.A (GNFT) France $0.204B 0.00
Rani Therapeutics Holdings (RANI) United States $0.203B 0.00
2seventy Bio (TSVT) United States $0.203B 0.00
Ventyx Biosciences (VTYX) United States $0.203B 0.00
Biomea Fusion (BMEA) United States $0.203B 0.00
23andMe Holding (ME) United States $0.194B 0.00
Coherus BioSciences (CHRS) United States $0.194B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.193B 0.00
Greenwich LifeSciences (GLSI) United States $0.190B 0.00
Innate Pharma S.A (IPHA) France $0.190B 0.00
Invivyd (IVVD) United States $0.189B 0.00
Abeona Therapeutics (ABEO) United States $0.187B 0.00
Trevi Therapeutics (TRVI) United States $0.187B 0.00
XBiotech (XBIT) United States $0.186B 0.00
Oncobiologics (OTLK) United States $0.180B 0.00
Compugen (CGEN) Israel $0.179B 0.00
Elevation Oncology (ELEV) United States $0.176B 0.00
X4 Pharmaceuticals (XFOR) United States $0.171B 0.00
INmune Bio (INMB) United States $0.168B 0.00
Alimera Sciences (ALIM) United States $0.166B 0.00
Zura Bio (ZURA) United States $0.164B 0.00
Vigil Neuroscience (VIGL) United States $0.163B 0.00
Caribou Biosciences (CRBU) United States $0.162B 0.00
Repare Therapeutics (RPTX) Canada $0.161B 0.00
Syros Pharmaceuticals (SYRS) United States $0.160B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.159B 0.00
Rezolute (RZLT) United States $0.159B 0.00
Adverum Biotechnologies (ADVM) United States $0.158B 0.00
Lifecore Biomedical (LFCR) United States $0.158B 0.00
Inventiva S.A (IVA) France $0.156B 0.00
Compass Therapeutics (CMPX) United States $0.153B 0.00
Puma Biotechnology (PBYI) United States $0.150B 9.42
ScPharmaceuticals (SCPH) United States $0.149B 0.00
I-Mab (IMAB) China $0.149B 0.00
Kodiak Sciences (KOD) United States $0.148B 0.00
Boundless Bio (BOLD) United States $0.146B 0.00
G1 Therapeutics (GTHX) United States $0.145B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.143B 0.00
Semper Paratus Acquisition (TVGN) United States $0.137B 0.00
TELA Bio (TELA) United States $0.132B 0.00
Werewolf Therapeutics (HOWL) United States $0.131B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.128B 0.00
ATyr Pharma (ATYR) United States $0.126B 0.00
Sagimet Biosciences (SGMT) United States $0.126B 0.00
Cellectis S.A (CLLS) France $0.125B 0.00
Adlai Nortye (ANL) Cayman Islands $0.124B 0.00
Nuvectis Pharma (NVCT) United States $0.124B 0.00
Cardiff Oncology (CRDF) United States $0.121B 0.00
BioStem Technologies (BSEM) $0.120B 0.00
Adagene (ADAG) China $0.118B 0.00
Gossamer Bio (GOSS) United States $0.118B 0.00
CervoMed (CRVO) United States $0.117B 0.00
Rapt Therapeutics (RAPT) United States $0.116B 0.00
Seer (SEER) United States $0.115B 0.00
Opthea (OPT) Australia $0.114B 0.00
Omega Therapeutics (OMGA) United States $0.112B 0.00
Adicet Bio (ACET) United States $0.111B 0.00
Akoya Biosciences (AKYA) United States $0.109B 0.00
Affimed (AFMD) Germany $0.108B 0.00
CytomX Therapeutics (CTMX) United States $0.108B 6.90
Seres Therapeutics (MCRB) United States $0.107B 0.00
Immunic (IMUX) United States $0.107B 0.00
Coya Therapeutics (COYA) United States $0.105B 0.00
Bluebird Bio (BLUE) United States $0.105B 0.00
Sangamo Therapeutics (SGMO) United States $0.104B 0.00
BeyondSpring (BYSI) United States $0.103B 0.00
Allakos (ALLK) United States $0.103B 0.00
PDS Biotechnology (PDSB) United States $0.102B 0.00
BioHarvest Sciences (CNVCD) Canada $0.099B 0.00
Athira Pharma (ATHA) United States $0.097B 0.00
DBV Technologies S.A (DBVT) France $0.096B 0.00
VistaGen Therapeutics (VTGN) United States $0.095B 0.00
Elutia (ELUT) United States $0.093B 0.00
InflaRx (IFRX) Germany $0.092B 0.00
Eton Pharmaceuticals (ETON) United States $0.091B 89.00
DiaMedica Therapeutics (DMAC) United States $0.091B 0.00
Clearside Biomedical (CLSD) United States $0.089B 0.00
Connect Biopharma Holdings (CNTB) United States $0.088B 0.00
Verastem (VSTM) United States $0.088B 0.00
Cognition Therapeutics (CGTX) United States $0.087B 0.00
Galena Biopharma (SLS) United States $0.087B 0.00
IO Biotech (IOBT) Denmark $0.086B 0.00
Gritstone Bio (GRTS) United States $0.085B 0.00
Ikena Oncology (IKNA) United States $0.084B 0.00
Elicio Therapeutics (ELTX) United States $0.084B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.084B 0.00
Vor Biopharma (VOR) $0.079B 0.00
Oncolytics Biotech (ONCY) Canada $0.078B 0.00
Precision BioSciences (DTIL) United States $0.077B 0.00
BioAtla (BCAB) United States $0.077B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.076B 0.00
Checkpoint Therapeutics (CKPT) United States $0.076B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.075B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.075B 0.00
Entera Bio (ENTX) Israel $0.074B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.074B 0.00
HOOKIPA Pharma (HOOK) United States $0.074B 0.00
Spero Therapeutics (SPRO) United States $0.073B 2.67
Barinthus Biotherapeutics (BRNS) United Kingdom $0.071B 0.00
Earth Science Tech (ETST) United States $0.071B 0.00
Aileron Therapeutics (ALRN) United States $0.070B 0.00
Alpha Teknova (TKNO) United States $0.069B 0.00
Benitec Biopharma (BNTC) United States $0.068B 0.00
Instil Bio (TIL) United States $0.068B 0.00
LENZ Therapeutics (LENZ) United States $0.068B 0.00
Intensity Therapeutics (INTS) United States $0.067B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.067B 0.00
Cue Biopharma (CUE) United States $0.066B 0.00
Annovis Bio (ANVS) United States $0.065B 0.00
MediciNova (MNOV) United States $0.065B 0.00
LakeShore Biopharma (LSB) China $0.065B 0.00
Kronos Bio (KRON) United States $0.065B 0.00
AN2 Therapeutics (ANTX) United States $0.065B 0.00
Passage Bio (PASG) United States $0.065B 0.00
AVROBIO (AVRO) United States $0.064B 0.00
Rallybio (RLYB) United States $0.064B 0.00
Genelux (GNLX) United States $0.064B 0.00
VTv Therapeutics (VTVT) United States $0.063B 0.00
Turnstone Biologics (TSBX) United States $0.062B 0.00
Celularity (CELU) United States $0.062B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.062B 0.00
Atara Biotherapeutics (ATRA) United States $0.062B 0.00
Cidara Therapeutics (CDTX) United States $0.061B 0.00
Dyadic (DYAI) United States $0.061B 0.00
Theratechnologies (THTX) Canada $0.060B 0.00
Enzo Biochem (ENZ) United States $0.060B 0.00
Genenta Science S.p.A (GNTA) Italy $0.059B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.059B 0.00
Lantern Pharma (LTRN) United States $0.058B 0.00
Bionano Genomics (BNGO) United States $0.055B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.054B 0.00
Immix Biopharma (IMMX) United States $0.054B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.054B 0.00
Leap Therapeutics (LPTX) United States $0.054B 0.00
CalciMedica (CALC) United States $0.052B 0.00
BioXcel Therapeutics (BTAI) United States $0.051B 0.00
Kezar Life Sciences (KZR) United States $0.050B 0.00
Clene (CLNN) United States $0.049B 0.00
Ocean Biomedical (OCEA) United States $0.049B 0.00
IN8bio (INAB) United States $0.048B 0.00
ARCA Biopharma (ABIO) United States $0.048B 0.00
Curis (CRIS) United States $0.048B 0.00
Dare Bioscience (DARE) United States $0.045B 0.00
Beyond Air (XAIR) United States $0.045B 0.00
Immuneering (IMRX) United States $0.045B 0.00
NextCure (NXTC) United States $0.045B 0.00
Ocuphire Pharma (OCUP) United States $0.043B 0.00
HCW Biologics (HCWB) United States $0.042B 0.00
Aadi Bioscience (AADI) United States $0.042B 0.00
Carmell (CTCX) United States $0.041B 0.00
Lexaria Bioscience (LEXX) Canada $0.040B 0.00
Aligos Therapeutics (ALGS) United States $0.039B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.039B 0.00
OKYO Pharma (OKYO) $0.038B 0.00
Xilio Therapeutics (XLO) United States $0.038B 0.00
Fortress Biotech (FBIO) United States $0.037B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.037B 0.00
Cyclo Therapeutics (CYTH) United States $0.034B 0.00
Estrella Immunopharma (ESLA) United States $0.034B 0.00
Eyenovia (EYEN) United States $0.034B 0.00
NKGen Biotech (NKGN) United States $0.034B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.033B 0.00
MiNK Therapeutics (INKT) United States $0.032B 0.00
Quince Therapeutics (QNCX) United States $0.031B 0.00
Promis Neurosciences (PMN) Canada $0.031B 0.00
Lisata Therapeutics (LSTA) United States $0.030B 0.00
Pluri (PLUR) Israel $0.029B 0.00
SAB Biotherapeutics (SABS) United States $0.029B 0.00
Bolt Biotherapeutics (BOLT) United States $0.029B 0.00
RenovoRx (RNXT) United States $0.028B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Biora Therapeutics (BIOR) United States $0.027B 0.00
Spruce Biosciences (SPRB) United States $0.027B 0.00
BRIACELL THERAP (BCTX) Canada $0.026B 0.00
Equillium (EQ) United States $0.025B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.025B 0.00
Cocrystal Pharma (COCP) United States $0.024B 0.00
UNITY Biotechnology (UBX) United States $0.024B 0.00
Aprea Therapeutics (APRE) United States $0.024B 0.00
BioAffinity Technologies (BIAF) United States $0.023B 0.00
Femasys (FEMY) United States $0.023B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.021B 0.00
Forte Biosciences (FBRX) United States $0.020B 0.00
Longeveron (LGVN) United States $0.020B 0.00
Vincerx Pharma (VINC) United States $0.020B 0.00
Orgenesis (ORGS) United States $0.020B 0.00
Lumos Pharma (LUMO) United States $0.019B 0.00
Cara Therapeutics (CARA) United States $0.019B 0.00
Synlogic (SYBX) United States $0.019B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.019B 0.00
Apollomics (APLM) United States $0.018B 0.00
VBI Vaccines (VBIV) United States $0.017B 0.00
KALA BIO (KALA) United States $0.017B 0.00
Evaxion Biotech (EVAX) Denmark $0.017B 0.00
Monopar Therapeutics (MNPR) United States $0.016B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
Aptose Biosciences (APTO) Canada $0.016B 0.00
Sensei Biotherapeutics (SNSE) United States $0.016B 0.00
Aytu BioPharma (AYTU) United States $0.016B 0.00
Purple Biotech (PPBT) Israel $0.015B 0.00
Galecto (GLTO) Denmark $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.014B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.013B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.013B 0.00
Organovo Holdings (ONVO) United States $0.013B 0.00
Biorestorative Therapies (BRTX) United States $0.013B 0.00
Chemomab Therapeutics (CMMB) Israel $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.012B 0.00
AEterna Zentaris (AEZS) Canada $0.012B 0.00
Senti Biosciences (SNTI) United States $0.011B 0.00
Elevai Labs (ELAB) United States $0.011B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.011B 0.00
Vaccinex (VCNX) United States $0.011B 0.00
Imunon (IMNN) United States $0.011B 0.00
Eterna Therapeutics (ERNA) United States $0.010B 0.00
Kintara Therapeutics (KTRA) United States $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
ABVC BioPharma (ABVC) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Telesis Bio (TBIO) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
Cadrenal Therapeutics (CVKD) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
Trevena (TRVN) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.007B 0.00
Bionomics (BNOX) Australia $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Sunshine Biopharma (SBFM) United States $0.006B 0.00
Kineta (KA) United States $0.006B 0.00
BioCardia (BCDA) United States $0.006B 0.00
Tenax Therapeutics (TENX) United States $0.006B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.006B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.006B 0.00
Enveric Biosciences (ENVB) United States $0.006B 0.00
Synaptogenix (SNPX) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Psyence Biomedical (PBM) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Entero Therapeutics (ENTO) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Virios Therapeutics (VIRI) United States $0.005B 0.00
Atrinsic (PTIX) United States $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
NexImmune (NEXI) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Cingulate (CING) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Invo BioScience (INVO) United States $0.004B 0.00
Novogen (KZIA) Australia $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.003B 0.36
Alzamend Neuro (ALZN) United States $0.003B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Exicure (XCUR) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
GeoVax Labs (GOVX) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
ThermoGenesis Holdings (THMO) United States $0.002B 0.00
Seelos Therapeutics (SEEL) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Mustang Bio (MBIO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.001B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Dermata Therapeutics (DRMA) United States $0.001B 0.00
Allarity Therapeutics (ALLR) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
CNS Pharmaceuticals (CNSP) United States $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00